Evidence map›Paper›PMID 39268101›Full record

ArticleJournal of thoracic disease2024

Impact of imaging features on selecting limited lymph node resection for cT1N0M0 lung cancer.

Hua He, Wenteng Hu, Changsheng Yi, Shuo Sun, Yu Zhou, Xiaofei Zeng, Quan Zhang, Ruijiang Lin, Peng Yue, Minjie Ma and 1 more

Abstract read
In one paragraph

Article in Journal of thoracic disease, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Hua He *The First School of Clinical Medicine, Lanzhou University, Lanzhou, China.
Wenteng Hu *Department of Thoracic Surgery, The First Hospital of Lanzhou University, Lanzhou, China.
Changsheng Yi *Department of Thoracic Surgery, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China.
Shuo SunDepartment of Thoracic Surgery, The First Hospital of Lanzhou University, Lanzhou, China.
Yu ZhouDepartment of Thoracic Surgery, Affiliated Hospital of North Sichuan Medical College, Nanchong, China.
Xiaofei ZengDepartment of Cardiothoracic Surgery, The First Affiliated Hospital of Chengdu Medical College, School of Clinical Medicine, Chengdu Medical College, Chengdu, China.
Quan ZhangDepartment of Thoracic Surgery, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, China.
Ruijiang LinDepartment of Thoracic Surgery, The First Hospital of Lanzhou University, Lanzhou, China.
Peng YueDepartment of Thoracic Surgery, The First Hospital of Lanzhou University, Lanzhou, China.
Minjie MaDepartment of Thoracic Surgery, The First Hospital of Lanzhou University, Lanzhou, China.
Chang ChenThe First School of Clinical Medicine, Lanzhou University, Lanzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Controversy still exists in the medical community regarding the performance of limited mediastinal lymphadenectomy (LML) in early-stage lung cancer. The objective of this study was to identify predictors of mediastinal lymph node (mLN) status and analyze its role in guiding surgical strategy. Methods: A retrospective cohort study was conducted on 2,834 surgical patients with peripheral cT1N0M0 non-small cell lung cancer between 2016 and 2018. Logistic regression was employed to identify predictors of N2 metastasis. Prognosis was compared between groups and independent prognostic factors were identified using Kaplan-Meier and multivariate Cox analysis. Results: There were 2,126 patients with systematic mLN dissection and 708 with LML. The multivariate analysis showed that N2 metastasis were associated with tumor size and consolidation tumor ratio (CTR). Patients in group A, with CTR >0.5 and tumor size ≤1 cm or CTR ≤0.5, had a significantly lower rate of N2 metastasis compared to those in group B, with CTR >0.5 and tumor size >1 cm (14.2% Conclusions: The combination of CTR and tumor size can predict mLN metastasis and procedure-specific outcome (SND

Indexed as

Early-stage lung cancerlimited mediastinal lymphadenectomy (LML)mediastinal lymph node metastasis (mLN metastasis)systematic lymph node dissection (SND)

Identifiers

PMID39268101
PMCPMC11388245

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.